NCT05399498: Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
- State
- Completed
- Phase
- Phase 2
- People
- 10 taking part
- Started
- 1 Nov 2023
- Primary completion
- 1 Dec 2025
- Arms
- Experimental: Psilocybin
- Results
- Posted on the registry
- 1 Jun 2022: Trial registered
- 1 Nov 2023: Trial started
- 1 Dec 2025: Trial completed
- 29 Oct 2026: Trial results posted